Published 7 days ago • loading... • Updated 6 days ago

PMcardio STEMI AI ECG tool earns US FDA breakthrough device designation - Cardiovascular News

Summary by Cardiovascular News

Powerful Medical has been granted breakthrough device designation by the US Food and Drug Administration (FDA) for its PMcardio ST-segment elevation myocardial infarction (STEMI) artificial intelligence (AI) electrocardiogram (ECG) model. PMcardio is capable of detecting both STEMI and STEMI equivalents on the ECG—aligning with the emerging emphasis on a paradigm shift towards occlusion myocardial infarction (OMI) diagnosis and bridging a vital …

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All

Left

Center

Right

Cardiac Interventions Today

Elucid Names Dr. Amir Ahmadi as a Chief Scientific Advisor - Cardiac Interventions Today

March 27, 2025—Elucid recently announced that cardiologist Amir Ahmadi, MD, has joined as a Chief Scientific Advisor and will lead the company’s clinical strategy. The company advised that this and other appointments have been made as Elucid prepares for the commercial launch of its PlaqueIQ image analysis software. According to Elucid, Dr. Ahmadi is Clinical Associate Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount S…

6 days ago

Read Full Article